191 related articles for article (PubMed ID: 28170371)
1. Imaging tests in staging and surveillance of non-metastatic breast cancer: changes in routine clinical practice and cost implications.
De Placido S; De Angelis C; Giuliano M; Pizzi C; Ruocco R; Perrone V; Bruzzese D; Tommasielli G; De Laurentiis M; Cammarota S; Arpino G; Arpino G
Br J Cancer; 2017 Mar; 116(6):821-827. PubMed ID: 28170371
[TBL] [Abstract][Full Text] [Related]
2. Impact of Pretreatment Combined (18)F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Staging on Radiation Therapy Treatment Decisions in Locally Advanced Breast Cancer.
Ng SP; David S; Alamgeer M; Ganju V
Int J Radiat Oncol Biol Phys; 2015 Sep; 93(1):111-7. PubMed ID: 26279029
[TBL] [Abstract][Full Text] [Related]
3. Variation in the use of advanced imaging at the time of breast cancer diagnosis in a statewide registry.
Henry NL; Braun TM; Breslin TM; Gorski DH; Silver SM; Griggs JJ
Cancer; 2017 Aug; 123(15):2975-2983. PubMed ID: 28301680
[TBL] [Abstract][Full Text] [Related]
4. Cost-effectiveness analysis of routine surveillance imaging of patients with diffuse large B-cell lymphoma in first remission.
Huntington SF; Svoboda J; Doshi JA
J Clin Oncol; 2015 May; 33(13):1467-74. PubMed ID: 25823735
[TBL] [Abstract][Full Text] [Related]
5. Positron Emission Tomography/Magnetic Resonance Imaging for Local Tumor Staging in Patients With Primary Breast Cancer: A Comparison With Positron Emission Tomography/Computed Tomography and Magnetic Resonance Imaging.
Grueneisen J; Nagarajah J; Buchbender C; Hoffmann O; Schaarschmidt BM; Poeppel T; Forsting M; Quick HH; Umutlu L; Kinner S
Invest Radiol; 2015 Aug; 50(8):505-13. PubMed ID: 26115367
[TBL] [Abstract][Full Text] [Related]
6. Value analysis of postoperative staging imaging for asymptomatic, early-stage breast cancer: implications of clinical variation on utility and cost.
Pellet AC; Erten MZ; James TA
Am J Surg; 2016 Jun; 211(6):1084-8. PubMed ID: 26545344
[TBL] [Abstract][Full Text] [Related]
7. Use of imaging for staging of early-stage breast cancer in two integrated health care systems: adherence with a choosing wisely recommendation.
Hahn EE; Tang T; Lee JS; Munoz-Plaza C; Adesina JO; Shen E; Rowley B; Maeda JL; Mosen DM; Ruckdeschel JC; Gould MK
J Oncol Pract; 2015 May; 11(3):e320-8. PubMed ID: 25901056
[TBL] [Abstract][Full Text] [Related]
8. Role of 2-[18F] fluoro-2-deoxy-D-glucose-positron emission tomography/computed tomography in the post-therapy surveillance of breast cancer.
Chang HT; Hu C; Chiu YL; Peng NJ; Liu RS
PLoS One; 2014; 9(12):e115127. PubMed ID: 25517451
[TBL] [Abstract][Full Text] [Related]
9. The value of PET/CT with FES or FDG tracers in metastatic breast cancer: a computer simulation study in ER-positive patients.
Koleva-Kolarova RG; Greuter MJ; van Kruchten M; Vermeulen KM; Feenstra T; Buskens E; Glaudemans AW; de Vries EF; de Vries EG; Hospers GA; de Bock GH
Br J Cancer; 2015 May; 112(10):1617-25. PubMed ID: 25880006
[TBL] [Abstract][Full Text] [Related]
10. Cost-effectiveness of FDG-PET/CT for cytologically indeterminate thyroid nodules: a decision analytic approach.
Vriens D; Adang EM; Netea-Maier RT; Smit JW; de Wilt JH; Oyen WJ; de Geus-Oei LF
J Clin Endocrinol Metab; 2014 Sep; 99(9):3263-74. PubMed ID: 24873995
[TBL] [Abstract][Full Text] [Related]
11. Current role of bone scan with phosphonates in the follow-up of breast cancer.
Maffioli L; Florimonte L; Pagani L; Butti I; Roca I
Eur J Nucl Med Mol Imaging; 2004 Jun; 31 Suppl 1():S143-8. PubMed ID: 15088128
[TBL] [Abstract][Full Text] [Related]
12. Impact of [18F]-2-fluorodeoxyglucose-positron emission tomography/computed tomography on previously untreated head and neck cancer patients.
Fleming AJ; Smith SP; Paul CM; Hall NC; Daly BT; Agrawal A; Schuller DE
Laryngoscope; 2007 Jul; 117(7):1173-9. PubMed ID: 17603315
[TBL] [Abstract][Full Text] [Related]
13. Use of posttreatment imaging and biomarkers in survivors of early-stage breast cancer: Inappropriate surveillance or necessary care?
Hahn EE; Tang T; Lee JS; Munoz-Plaza CE; Shen E; Rowley B; Maeda JL; Mosen DM; Ruckdeschel JC; Gould MK
Cancer; 2016 Mar; 122(6):908-16. PubMed ID: 26650715
[TBL] [Abstract][Full Text] [Related]
14. Metastatic Disease to the Breast From Extramammary Malignancies: A Multimodality Pictorial Review.
Sippo DA; Kulkarni K; Carlo PD; Lee B; Eisner D; Cimino-Mathews A; Harvey SC
Curr Probl Diagn Radiol; 2016; 45(3):225-32. PubMed ID: 26293973
[TBL] [Abstract][Full Text] [Related]
15. Assessment of multifocality and axillary nodal involvement in early-stage breast cancer patients using 18F-FDG PET/CT compared to contrast-enhanced and diffusion-weighted magnetic resonance imaging and sentinel node biopsy.
Ergul N; Kadioglu H; Yildiz S; Yucel SB; Gucin Z; Erdogan EB; Aydin M; Muslumanoglu M
Acta Radiol; 2015 Aug; 56(8):917-23. PubMed ID: 25013091
[TBL] [Abstract][Full Text] [Related]
16. Breast cancer staging in a single session: whole-body PET/CT mammography.
Heusner TA; Kuemmel S; Umutlu L; Koeninger A; Freudenberg LS; Hauth EA; Kimmig KR; Forsting M; Bockisch A; Antoch G
J Nucl Med; 2008 Aug; 49(8):1215-22. PubMed ID: 18632831
[TBL] [Abstract][Full Text] [Related]
17. Clinical utility of F-18 FDG PET/CT in recurrent breast carcinoma.
Manohar K; Mittal BR; Senthil R; Kashyap R; Bhattacharya A; Singh G
Nucl Med Commun; 2012 Jun; 33(6):591-6. PubMed ID: 22334135
[TBL] [Abstract][Full Text] [Related]
18. [Analysis of cost-effectiveness in the diagnosis of fever of unknown origin and the role of (18)F-FDG PET-CT: a proposal of diagnostic algorithm].
Becerra Nakayo EM; García Vicente AM; Soriano Castrejón AM; Mendoza Narváez JA; Talavera Rubio MP; Poblete García VM; Cordero García JM
Rev Esp Med Nucl Imagen Mol; 2012; 31(4):178-86. PubMed ID: 23067686
[TBL] [Abstract][Full Text] [Related]
19. Improving the accuracy of target volume delineation by combined use of computed tomography, magnetic resonance imaging and positron emission tomography in head and neck carcinomas.
Chauhan D; Rawat S; Sharma MK; Ahlawat P; Pal M; Gupta G; Dewan A; Gupta M; Sharma S; Dodagoudar C; Pahuja A; Mitra S; Sharma SK
J Cancer Res Ther; 2015; 11(4):746-51. PubMed ID: 26881512
[TBL] [Abstract][Full Text] [Related]
20. Treatment Response Evaluation of Breast Cancer after Neoadjuvant Chemotherapy and Usefulness of the Imaging Parameters of MRI and PET/CT.
An YY; Kim SH; Kang BJ; Lee AW
J Korean Med Sci; 2015 Jun; 30(6):808-15. PubMed ID: 26028936
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
